Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 70771-1621
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 70771-1621). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
3c12b083 Aca8 4924 A6d9 D2cac13ef19b 02
This is a description of a medication with the NDC (National Drug Code) number 70774-1621. The medication is in tablet form and contains 153 mg of Emtricitabine, Tenofovir Disoproxil, and Fumarate. The text also includes some errors and characters that do not make sense, making it difficult to understand the full description.*
3c12b083 Aca8 4924 A6d9 D2cac13ef19b 03
3c12b083 Aca8 4924 A6d9 D2cac13ef19b 04
Emtricitabine and Tenofovir Disoproxil Fumarate Tablets are a prescription medication used for treating HIV. Each tablet contains 200 mg of emtricitabine and 300 mg of tenofovir disoproxil fumarate. The usual dosage information is included in the package insert. It should be stored between 20°C to 25°C with permitted excursions to 15°C to 30°C. The package is child-resistant and the medication guide is available at the mentioned website or by calling the provided number. This medication is manufactured by Cala Healthcare Ltd in Ahmedabad, India.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.